| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/24/2013 | US8541457 Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitors |
| 09/24/2013 | US8541456 Roflumilast for the treatment of diabetes mellitus type 2 |
| 09/24/2013 | US8541455 Derivatives of 2-pyridin-2-yl-pyrazol-3(2H)-one, preparation and therapeutic use thereof as HIF activators |
| 09/24/2013 | US8541454 Antiseptic based on bispyridinium alkanes |
| 09/24/2013 | US8541453 Modulators of ATP-binding cassette transporters |
| 09/24/2013 | US8541452 Method for treating binge-eating disorder |
| 09/24/2013 | US8541451 Crystalline freebase forms of a biphenyl compound |
| 09/24/2013 | US8541450 Process for the preparation of chiral 8-(3-aminopiperidin-1yl)-xanthines |
| 09/24/2013 | US8541449 Substituted isoquinolines and isoquinolinones as Rho kinase inhibitors |
| 09/24/2013 | US8541448 Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| 09/24/2013 | US8541447 3-substituted-2-(arlyalkyl)-1-azabicycloalkanes and methods of use thereof |
| 09/24/2013 | US8541446 (2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofurn-2-carboxamide, novel salt forms, and methods of use thereof |
| 09/24/2013 | US8541445 Pyrazolopyridines |
| 09/24/2013 | US8541444 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors |
| 09/24/2013 | US8541443 Crystal of diamine derivative and method of producing same |
| 09/24/2013 | US8541442 Indole derivatives as anticancer agents |
| 09/24/2013 | US8541441 Selective glycosidase inhibitors and uses thereof |
| 09/24/2013 | US8541440 Derivatives of 5-pyridinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics |
| 09/24/2013 | US8541438 Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines |
| 09/24/2013 | US8541437 Substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles, methods for the production and use thereof |
| 09/24/2013 | US8541436 Morphinan compounds |
| 09/24/2013 | US8541435 Niacin compositions for reduction of amyloid beta peptide 42 (abeta 42) production and for treatment of Alzheimer's disease (AD) |
| 09/24/2013 | US8541434 Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| 09/24/2013 | US8541433 Combination comprising macitentan and paclitaxel for treating multi-drug resistant ovarian cancer |
| 09/24/2013 | US8541432 Heterobicyclic carboxamides as inhibitors for kinases |
| 09/24/2013 | US8541431 Pyrimidine non-classical cannabinoid compounds and related methods of use |
| 09/24/2013 | US8541430 Fused thiazolo and oxazolo pyrimidinones |
| 09/24/2013 | US8541429 Pyrazolo quinazoline derivatives, process for their preparation and their use as kinase inhibitors |
| 09/24/2013 | US8541428 Heterocyclic derivatives, pharmaceutical compositions and methods of use thereof |
| 09/24/2013 | US8541427 Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use |
| 09/24/2013 | US8541426 Pharmaceutical compositions and methods of treating dry eye disorders |
| 09/24/2013 | US8541425 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |
| 09/24/2013 | US8541424 Anti-viral compounds |
| 09/24/2013 | US8541423 Methods and compositions for treating pain |
| 09/24/2013 | US8541422 Methods for the treatment or prophylaxis of thrombosis or embolism |
| 09/24/2013 | US8541421 Methods of enhancing sweet taste of compositions using substituted thieno{2,3-D}pyrimidines |
| 09/24/2013 | US8541420 Ketolide compounds having antimicrobial activity |
| 09/24/2013 | US8541418 Inhibitors of polo-like kinase |
| 09/24/2013 | US8541417 Poly (ADP-ribose) polymerase (PARP) inhibitors |
| 09/24/2013 | US8541416 Method for treating a sleep disorder with a dosage form of a zopiclone or eszopiclone L-malate salt |
| 09/24/2013 | US8541415 Targeting an HIV-1 nef-host cell kinase complex |
| 09/24/2013 | US8541414 Pyridazinone compound and use thereof as herbicides |
| 09/24/2013 | US8541413 Sustained release eye drop formulations |
| 09/24/2013 | US8541412 Dihydroindolone compounds, a process for their preparation and pharmaceutical compositions containing them |
| 09/24/2013 | US8541411 Benzimidazole derivatives as PI3 kinase inhibitors |
| 09/24/2013 | US8541410 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 09/24/2013 | US8541409 Carbamoyloxy arylalkanoyl arylpiperazine analgesics |
| 09/24/2013 | US8541408 Aminodihydrothiazine derivatives substituted with a cyclic group |
| 09/24/2013 | US8541406 Thiadiazole derivatives for the treatment of neurodegenerative diseases |
| 09/24/2013 | US8541405 Methods for the preparation of Ivabradine sulfate and form I crystal thereof |
| 09/24/2013 | US8541404 Inhibitors of the human aldosterone synthase CYP11B2 |
| 09/24/2013 | US8541403 Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency |
| 09/24/2013 | US8541402 Viral polymerase inhibitors |
| 09/24/2013 | US8541401 Flavorant ester salts of polycarboxylic acids and methods for immobilizing and delivering flavorants containing hydroxyl groups |
| 09/24/2013 | US8541400 Monoacyl lipid, diacyl glycerol, tocopherol, and fragmentation agent; capable of self-dispersing to provide colloidal non-lamellar particles upon contact with an aqueous fluid; controlled-release formulations and for solubilising relatively insoluble compounds |
| 09/24/2013 | US8541399 Solvent-based sterilisation of pharmaceuticals |
| 09/24/2013 | US8541398 Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs |
| 09/24/2013 | US8541397 Alkyne and alkene derivatives as sphingosine 1-phosphate-1 receptor modulators |
| 09/24/2013 | US8541396 Morpholin-4-ium 4 methoxyphenyl (morpholino) phosphinodithioate (GYY4137) as a novel vasodilator agent |
| 09/24/2013 | US8541395 Use of telocinobufagin as an analgesic in the treatment of acute and chronic pains |
| 09/24/2013 | US8541394 Aminoglycoside antibiotics |
| 09/24/2013 | US8541393 Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin |
| 09/24/2013 | US8541392 Polymer controlled induced viscosity fiber system and uses thereof |
| 09/24/2013 | US8541391 Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl-1H-benzimidazole |
| 09/24/2013 | US8541390 Treatment of cancer by inhibition of IGFBPs and clusterin |
| 09/24/2013 | US8541383 Synergistic phytochemical composition for the treatment of obesity |
| 09/24/2013 | US8541381 Solvent extraction, concentrating under vacuum, dispersing dry powder in a polar organic solvent, washing with water; enriching product by giving an aqueous alkali wash to the polar organic solvent extractives of Bacopa crude extract and a charcoal treatment to the alkali washed bacopa saponin fraction |
| 09/24/2013 | US8541380 C-aryl glucoside SGLT2 inhibitors and pharmaceutical compositions comprising same |
| 09/24/2013 | US8541363 Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their use |
| 09/24/2013 | US8541362 Cyclopropyl compounds and compositions for delivering active agents |
| 09/24/2013 | US8541360 Parenteral formulations comprising sugar-based esters and ethers |
| 09/24/2013 | US8541359 Pharmaceutical compositions and methods for peptide treatment |
| 09/24/2013 | US8541343 Chemical compounds and their use as pesticides |
| 09/24/2013 | US8541026 Sustained release formulations of opioid and nonopioid analgesics |
| 09/24/2013 | US8541025 Co-crystals and pharmaceutical formulations comprising the same |
| 09/24/2013 | US8541019 Palatable ductile chewable veterinary composition |
| 09/24/2013 | US8541017 Use of alginate matrices to control cell growth |
| 09/24/2013 | US8541014 Gamma-tocopherol therapy for restenosis prevention |
| 09/24/2013 | US8540985 Use of Hsp70 as a regulator of enzymatic activity |
| 09/24/2013 | US8540976 Poly (non-conjugated diene) based sunscreens |
| 09/24/2013 | US8540973 Refreshing cream foundation in gel form |
| 09/24/2013 | US8540964 Polyvalent conjugate vaccine for cancer |
| 09/24/2013 | US8540751 Spine distraction implant and method |
| 09/24/2013 | CA2773177C Novel crystals of substituted phenylalkanoic acid and method of producing the same |
| 09/24/2013 | CA2770851C Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 09/24/2013 | CA2767335C Pet food compositions including a sustained-release lipoic acid and methods of manufacture and use thereof |
| 09/24/2013 | CA2760867C A method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions |
| 09/24/2013 | CA2755554C Pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| 09/24/2013 | CA2746746C Arylcyclopropylacetamide derivatives useful as glucokinase activators |
| 09/24/2013 | CA2745721C Substituted piperidine spiro pyrrolidinone and piperidinones used as h3 modulators |
| 09/24/2013 | CA2737739C Heteroaryl antagonists of prostaglandin d2 receptors |
| 09/24/2013 | CA2728451C Salicylamide derivatives as nicotinic alpha 7 modulators |
| 09/24/2013 | CA2722028C 5-hydroxypyrimidine-4-carboxamide compound |
| 09/24/2013 | CA2708323C 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide for the treatment of post-traumatic stress disorder |
| 09/24/2013 | CA2704946C Compositions for the treatment of inflammation of the gastrointestinal tract |
| 09/24/2013 | CA2694403C Topical antibiotic composition for the prevention of lyme disease |
| 09/24/2013 | CA2692503C Dsrna for treating viral infection |
| 09/24/2013 | CA2691587C Potentiation of cancer chemotherapy by 7-(2,5-dihydro-4-imidazo [1,2-a] pyrine-3-yl-2,5-dioxo-ih-pyrrol-3-yl)-9-fluoro-1,2,3,4, tetrahydro-2-(1-piperidinyl-carbonyd-pyrrolo[3,2,1-jk][1,4]benzodiazepin |
| 09/24/2013 | CA2682064C Compositions for targeted imaging and therapy |
| 09/24/2013 | CA2680378C Method for determining physiological effects of hemoglobin |